Balchem - BCPC Stock Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Balchem in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BCPC shares.
View BCPC analyst ratings or view top-rated stocks.

1 equities research analysts have issued 1-year price targets for Balchem's shares. Their BCPC share price forecasts range from $140.00 to $140.00. On average, they anticipate the company's share price to reach $140.00 in the next year. This suggests a possible upside of 12.2% from the stock's current price.
View analysts price targets for BCPC or view top-rated stocks among Wall Street analysts.

Balchem's stock was trading at $122.11 at the beginning of 2023. Since then, BCPC stock has increased by 2.2% and is now trading at $124.75.
View the best growth stocks for 2023 here.

Balchem saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 315,300 shares, an increase of 25.1% from the February 28th total of 252,000 shares. Based on an average daily volume of 101,400 shares, the days-to-cover ratio is presently 3.1 days. Currently, 1.0% of the company's stock are short sold.
View Balchem's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Friday, May 5th 2023.
View our BCPC earnings forecast.

Balchem Co. (NASDAQ:BCPC) issued its earnings results on Thursday, October, 28th. The basic materials company reported $0.92 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.90 by $0.02. The basic materials company had revenue of $197.87 million for the quarter, compared to the consensus estimate of $204.80 million. Balchem had a trailing twelve-month return on equity of 11.68% and a net margin of 11.18%. During the same period in the prior year, the company earned $0.83 EPS.

Balchem declared an annual dividend on Tuesday, December 6th. Shareholders of record on Tuesday, December 27th will be paid a dividend of $0.71 per share on Friday, January 20th. This represents a dividend yield of 0.53%. The ex-dividend date is Friday, December 23rd. This is an increase from the stock's previous annual dividend of $0.64.
Read our dividend analysis for BCPC.

ETFs with the largest weight of Balchem (NASDAQ:BCPC) stock in their portfolio include Invesco S&P SmallCap Materials ETF (PSCM), VanEck Future of Food ETF (YUMY), ProShares Russell 2000 Dividend Growers ETF (SMDV), SPDR S&P 600 Small Cap Growth ETF (SLYG), iShares S&P Small-Cap 600 Growth ETF (IJT), Vanguard S&P Small-Cap 600 Growth ETF (VIOG), Invesco S&P SmallCap Low Volatility ETF (XSLV) and Xtrackers S&P SmallCap 600 ESG ETF (SMLE).

Balchem (NASDAQ:BCPC) pays an annual dividend of $0.71 per share and currently has a dividend yield of 0.58%. The company has been increasing its dividend for 12 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 21.85%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BCPC will have a dividend payout ratio of 16.44% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for BCPC.

25 employees have rated Balchem Chief Executive Officer Dino A. Rossi on Glassdoor.com. Dino A. Rossi has an approval rating of 85% among the company's employees. 62.0% of employees surveyed would recommend working at Balchem to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Balchem investors own include Ecolab (ECL), CVS Health (CVS), AbbVie (ABBV), Johnson & Johnson (JNJ), Lowe's Companies (LOW), Altria Group (MO), NVIDIA (NVDA), AT&T (T), Analog Devices (ADI) and Bristol-Myers Squibb (BMY).

Balchem trades on the NASDAQ under the ticker symbol "BCPC."

Balchem's stock is owned by many different retail and institutional investors. Top institutional investors include Conestoga Capital Advisors LLC (3.24%), Geneva Capital Management LLC (2.34%), Schroder Investment Management Group (2.17%), Dimensional Fund Advisors LP (2.04%), Geode Capital Management LLC (1.96%) and Clearbridge Investments LLC (1.59%). Insiders that own company stock include David B Fischer, Gunsteren Job Leonard Van, Scott C Mason and William A Backus.
View institutional ownership trends.

Shares of BCPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BCPC stock can currently be purchased for approximately $124.75.

Balchem (NASDAQ:BCPC) has a market capitalization of $4.01 billion and generates $942.36 million in revenue each year. The basic materials company earns $105.37 million in net income (profit) each year or $3.25 on an earnings per share basis.

The company employs 1,340 workers across the globe.

Balchem's mailing address is 52 Sunrise Park Road, NEW HAMPTON NY, 10958. The official website for the company is www.balchem.com. The basic materials company can be reached via phone at (845) 326-5600, via email at mabrush@balchem.com, or via fax at 845-326-5717.